Compound Detail
CHEMBL477772
PAZOPANIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL477772 |
| Name | PAZOPANIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | CUIHSIWYWATEQL-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
465
Targets
995
Activities
4
Assay Types
11
PK Parameters
20
Publications
5
Known Names
20
Indications
Molecular Properties
437.5
MW (Da)
3.14
ALogP
8
HBA
2
HBD
119.0
PSA (Ų)
0.49
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2009 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Carcinoma, Renal Cell Carcinoma, Renal Cell Neoplasms Neoplasms Ovarian Neoplasms Ovarian Neoplasms Sarcoma Sarcoma Breast Neoplasms Breast Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Central Nervous System Neoplasms Chondrosarcoma Dermatofibrosarcoma Fallopian Tube Neoplasms Gastrointestinal Stromal Tumors Gliosarcoma Hemangiosarcoma Kidney Neoplasms
ATC Classification
L01EX03
pazopanib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 719 meas. best 10.54
Kd 244 meas. best 8.74
Ki 30 meas. best 9.05
EC50 2 meas. best 6.59
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 220000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 657000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 1141000.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 1037011.73 | ng.hr.mL-1 | Homo sapiens |
| AUC | 279.5 | - | Chlorocebus sabaeus |
| CL | 1.4 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.4 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 1.4 | mL.min-1.kg-1 | Macaca mulatta |
| F | 72.0 | % | Rattus norvegicus |
| F | 47.0 | % | Canis lupus familiaris |
| F | 65.0 | % | Macaca mulatta |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37616488 | 10.1021/acs.jmedchem.3c00640 | MDA-MB-231 | 42 |
| 37616488 | 10.1021/acs.jmedchem.3c00640 | MCF7 | 26 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 18620382 | 10.1021/jm800566m | Mus musculus | 10 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 18183025 | 10.1038/nbt1358 | Epidermal growth factor receptor | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Unchecked | 9 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 18183025 | 10.1038/nbt1358 | Tyrosine-protein kinase ABL1 | 7 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| 25101911 | 10.1021/jm501177w | HepG2 | 6 |
| 38810335 | 10.1016/j.ejmech.2024.116527 | Unchecked | 5 |
| 18183025 | 10.1038/nbt1358 | Receptor-type tyrosine-protein kinase FLT3 | 5 |
| 37616488 | 10.1021/acs.jmedchem.3c00640 | Vascular endothelial growth factor receptor 2 | 5 |
| 18183025 | 10.1038/nbt1358 | Mast/stem cell growth factor receptor Kit | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 18620382 | 10.1021/jm800566m | HT-29 | 4 |
| 18620382 | 10.1021/jm800566m | NON-PROTEIN TARGET | 4 |
Data from ChEMBL 36 via Core Engine